Key result
Prophylactic norepinephrine reduces intraoperative lactate rise by ~0.13 mmol/L during major noncardiac surgery.
Why the study?
Prophylactic norepinephrine infusion is used to prevent intraoperative hypotension during major non-cardiac surgery, but its effects on haemodynamic stability, tissue perfusion, fluid administration, and postoperative outcomes remained uncertain.
Does prophylactic intraoperative norepinephrine infusion improve haemodynamic stability, tissue perfusion, fluid administration, and postoperative outcomes compared to standard reactive management in patients undergoing major non-cardiac surgery?
Meta-Analysis (n=1,688)
Does prophylactic intraoperative norepinephrine infusion improve haemodynamic stability, tissue perfusion, fluid administration, and postoperative outcomes compared to standard reactive management in patients undergoing major non-cardiac surgery?
Prophylactic intraoperative norepinephrine during major non-cardiac surgery slightly reduces intraoperative lactate rise and increases perioperative mean arterial pressure, though evidence certainty is low and effects on clinical complications remain exploratory.
Answers are grounded in this paper and cite their sources.
Prophylactic norepinephrine modestly attenuates lactate rise and supports MAP in major noncardiac surgery; extends meta-analytic evidence on surrogates but leaves clinical outcome benefits open.
INTRODUCTION: Prophylactic norepinephrine infusion has gained increasing attention to prevent intraoperative hypotension during major non-cardiac surgery, but its effect on haemodynamic stability, tissue perfusion, fluid administration, and postoperative outcomes remains uncertain. METHODS: PubMed, Embase, and Cochrane CENTRAL were searched through May 9, 2026 for randomised trials comparing prophylactic norepinephrine with standard reactive management. Outcomes included change in serum lactate, haemodynamic measures, fluid administration, and postoperative outcomes, including complications and mortality. Risk of bias and certainty of evidence were assessed using Cochrane Risk of Bias 2 (RoB 2) and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, respectively. Sensitivity analyses and trial sequential analysis (TSA) were performed. RESULTS: Eleven trials (1688 patients) were included. Prophylactic norepinephrine was associated with a lower rise in lactate (mean difference (MD) -0.13 mmol/L, 95% CI -0.25 to -0.01; P = 0.03; I²=67.2%), higher post-induction mean arterial pressure (MD 10.79 mmHg, 95% CI 5.53 to 16.04; P < 0.01; I²=95.3%), higher postoperative mean arterial pressure (MD 2.78 mmHg, 95% CI 0.63 to 4.92; P = 0.01; I²=69.8%). Prophylactic norepinephrine use was associated with lower crystalloid administration (MD-548.22 mL, 95% CI -1087.16 to -9.28, P = 0.05, I²=99%) although substantial heterogeneity and protocol-driven differences limit interpretation. Exploratory analyses suggested lower incidences of myocardial infarction (RR 0.25, 95% CI 0.06-0.98), pneumonia (RR 0.58, 95% CI 0.36-0.95), and 30 day-surgical site infection (RR 0.63, 95% CI 0.41-0.97). No statistically significant differences were demonstrated for acute kidney injury, atelectasis, length of stay, or mortality. Certainty of evidence was low for most outcomes. TSA indicated insufficient evidence to establish a definitive treatment effect. CONCLUSIONS: Prophylactic norepinephrine was associated with a statistically significant but small reduction in intraoperative lactate rise, higher post-induction and post-operative mean arterial pressures. Postoperative complication findings remain exploratory and require confirmation in adequately powered randomised trials. REGISTRATION: PROSPERO (CRD420261345140).
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2026) conducted a meta-analysis in Major non-cardiac surgery (n=1,688). Prophylactic intraoperative norepinephrine infusion vs. Standard reactive management was evaluated on Change in serum lactate (MD -0.13 mmol/L, 95% CI -0.25 to -0.01, p=0.03). Prophylactic norepinephrine infusion during major noncardiac surgery reduced intraoperative lactate rise and increased post-induction MAP.
Synapse has enriched 10 related papers. Consider them for comparative context: